
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Extranodal NK-T-cell lymphoma risk factors
Introduction
Overview
Overview
There is a strong association between with extranodal NK/T-cell lymphoma and EBV virus.There is a strong assosiation between Extranodal NK/T-cell lymphoma andFas(Po-1/CD95) mutations.
Risk Factors
Risk Factors
- There is a strong association between with extranodal NK/T-cell lymphoma and EBV virus.[1]
- Studies revealed that there is a constant assosiation between NK/T-cell lymphoma with EBV in the world.[2][3][4]
- There is a strong assosiation between Extranodal NK/T-cell lymphoma andFas(Po-1/CD95) mutations.[5]
References
References
- β Ng SB, Khoury JD (2009). “Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist”. Adv Anat Pathol. 16 (1): 40β55. doi:10.1097/PAP.0b013e3181916029. PMIDΒ 19098466.
- β Kanavaros P, Lescs MC, BriΓ¨re J, Divine M, Galateau F, Joab I; et al. (1993). “Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus”. Blood. 81 (10): 2688β95. PMIDΒ 8387835.
- β Mishima, Kenji; Horiuchi, Keisuke; Kojya, Shizuo; Takahashi, Hiroomi; Ohsawa, Masahiko; Aozasa, Katsuyuki (1994). “Epstein-barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from china and japan”. Cancer. 73 (12): 3041β3046. doi:10.1002/1097-0142(19940615)73:12<3041::AID-CNCR2820731224>3.0.CO;2-K. ISSNΒ 0008-543X.
- β Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F; et al. (1990). “Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma”. Lancet. 335 (8682): 128β30. doi:10.1016/0140-6736(90)90002-m. PMIDΒ 1967431.
- β Suda T, Takahashi T, Golstein P, Nagata S (1993). “Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family”. Cell. 75 (6): 1169β78. doi:10.1016/0092-8674(93)90326-l. PMIDΒ 7505205.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
